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The market for cannabis remains 
by far the largest drugs market 
in the EU. There has been a 
further increase in the indoor 
and outdoor cultivation of 
herbal cannabis in and close to 
consumer markets. 
More OCGs are involved in 
cocaine trafficking than any other 
criminal activity in the EU. The 
significant increase in production 
in Colombia has resulted in 
intensified trafficking activity to 
the EU.
75% of the OCGs involved in the 
drugs trade in the EU deal in 
more than just one illegal drug.
The market for illegal drugs is 
the largest criminal market in the 
European Union (EU). The drugs 
trade in the EU is conservatively 
estimated to generate around 
EUR 24 billion in revenue each 
year.
Around 35% of the Organised 
Crime Groups (OCGs) active in 
the EU on an international level 
are involved in the production, 
trafficking or distribution of illegal 
drugs.
The Balkan route remains the 
main entry route for the bulk of 
the heroin trafficked to the EU. 
However, there has been a partial 
shift in the trafficking of heroin 
from the Balkan route to the 
Caucasus route. 
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The market for synthetic drugs 
and NPS remains the most 
dynamic drugs market in the 
EU. Various synthetic drugs and 
continuously emerging New 
Psychoactive Substances (NPS) 
constitute a significant threat for 
public health in the EU.
Drugs are now widely traded 
online on various platforms. 
The sale of drugs via Darknet 
marketplaces is a significant 
threat and continues to expand.
Drug overdose deaths in Europe 
rose 6% to 8,441 in 2015, rising 
for the third consecutive year, 
driven by increasing use of 
synthetic opioids like fentanyl. 
The European Monitoring 
Centre for Drugs and Drugs 
Addiction (EMCDDA) warned that 
drug-related deaths in Europe 
could be much higher due to 
“systematic under-reporting in 
some countries” and delays in 
reporting.1
1 EMCDDA 2017, European Drug Report 2017, 
accessible at http://www.emcdda.europa.eu/edr2017_
en; Reuters 2017, Drug deaths on the rise in Europe for 
third year: report [06 June 2017], accessible at http://
af.reuters.com/article/worldNews/idAFKBN18X1W4  
The scale of money laundering 
activities in the EU is significant 
reflecting the immense profits 
generated by the OCGs involved 
in the drugs trade and other 
serious and organised crime. 
However, the global anti-
money laundering framework 
implemented by law enforcement 
and other authorities in the EU 
has shown to have a poor success 
rate in identifying and seizing 
illegal funds generated by criminal 
organisations. Barely 1% of 
criminal proceeds are confiscated 
by relevant authorities at EU 
level.2
2 Europol 2017, From Suspicion to Action - Converting 
financial intelligence into greater operational impact, 
accessible at https://www.europol.europa.eu/sites/
default/files/documents/ql-01-17-932-en-c_pf_final.
pdf 
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The European Drug Markets
Drug markets remain the largest criminal 
markets in the EU. More than one third 
of the criminal groups active in the EU 
are involved in the production, trafficking 
or distribution of various types of drugs. 
The trade in illicit drugs generates 
multi-billion euro profits for the groups 
involved in this criminal activity. The EU 
retail drug market is estimated to be 
worth at least EUR 24 billion a year.3 The 
immense profits generated from the 
trade in drugs fund various other criminal 
activities allowing OCGs to thrive and 
develop their criminal enterprises at the 
expense of the health, prosperity and 
security of EU citizens.
OCGs involved in drug trafficking rely 
heavily on corruption to facilitate their 
trafficking activities. They also make 
use of fraudulent documents such as 
fake import or company registration 
certificates to import illicit drugs among 
legal goods, to procure (pre-)precursors 
and purchase equipment used as part of 
production processes.
CRIMINAL GROUPS
The OCGs involved in the drugs trade 
are highly poly-criminal. More than 75% 
3 EMCDDA & Europol 2016, EU Drug Markets Report 
2016
of the OCGs involved in the trafficking 
of one drug also traffic and distribute 
other types of drugs. Some 65% of 
OCGs involved in the drug trade are 
simultaneously involved in other criminal 
activities such as the trade in counterfeit 
goods, THB and migrant smuggling. Drugs 
are also used as a means of payment 
among criminal groups. In the period 
between 2013 and March 2016, more 
than 60 nationalities were involved in 
drugs trafficking crimes in the EU.
Drugs are also used as a means of 
payment among criminal groups. 
Herbal cannabis and cannabis resin 
are exchanged for other drugs such as 
cocaine trafficked to the EU from South 
America, heroin smuggled via Turkey and 
methamphetamine produced in the EU.  
In some cases, couriers arriving in the EU 
with cocaine travel back to the country of 
origin with cannabis resin.
In an increasingly competitive market 
featuring multiple producers and 
distributors, OCGs engage in rivalries 
to stake territories and distribution 
channels. In some cases, OCG 
competition involves the use of violence 
and raids on the cultivation sites of rival 
groups.
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INTRODUCTION
TECHNOLOGY
Technology has an impact on 
the production methods used to 
manufacture drugs in the EU. Technical 
innovation and the accessibility of 
sophisticated equipment have allowed 
OCGs to maximise the production output 
of individual sites. Large-scale cannabis 
cultivation sites are often maintained 
using professional growing equipment 
such as climate control systems, CO2 and 
ozone generators. Similarly, laboratories 
manufacturing synthetic drugs feature 
advanced chemical equipment and 
production lines capable of producing 
synthetic drugs on an industrial scale.  
OCGs involved in the drugs trade are 
highly adept at exploiting communication 
technologies to facilitate their business. 
Encryption and other technical means 
of obfuscating lines of communication 
make it increasingly difficult for law 
enforcement authorities to identify and 
disrupt these OCGs.
Drone technology is expected to advance 
allowing drones to travel greater 
distances and carry heavier loads as 
well as making them more affordable. 
OCGs involved in drug trafficking will 
likely invest in drone technology for 
trafficking purposes in order to avoid 
checks at border crossing points, ports 
and airports.
HARM
The most immediate impact of the 
trade in illicit drugs is on the health of 
users. The consumption of all types of 
illicit drugs entails significant health risk 
with potentially lethal consequences. 
The consumption of cannabis may have 
serious health and social implications 
for some consumers, especially cannabis 
cultivated to feature a high THC content. 
Cannabis is the most frequently noted 
reason for first-time admission to drug 
treatment programmes in the EU. The 
use of heroin is associated with serious 
health harms including dependence, 
overdose and death; unsafe injection 
practices and multiple daily injections 
increase the risk for infectious diseases, 
such as HIV, hepatitis C virus (HCV) 
and other infections. The long-term 
effects of NPS are virtually unknown 
due to the frequent appearance of 
previously unknown NPS. Some NPS 
have proven extremely harmful to 
consumers. Synthetic drugs such as 
methamphetamine can be highly 
addictive and their consumption entails 
serious health risks including the risk of 
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lethal overdose.
Drug deaths on the 
rise in Europe for 
third year4
Drug overdose deaths in 
Europe rose 6% to 8,441 
in 2015, rising for the third 
consecutive year, driven by 
increasing use of synthetic 
opioids like fentanyl, 
according to the EMCDDA.
The agency warned that 
drug-related deaths in 
Europe could be much 
higher due to “systematic 
under-reporting in some 
countries” and delays in 
reporting.
4 EMCDDA 2017, European Drug 
Report 2017, accessible at http://
www.emcdda.europa.eu/edr2017_en; 
Reuters 2017, Drug deaths on the 
rise in Europe for third year: report 
[06 June 2017], accessible at http://
af.reuters.com/article/worldNews/
idAFKBN18X1W4 
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The environmental impact of the drugs 
trade is also considerable. The cultivation 
of cannabis increasingly entails the 
use of uncontrolled pesticides and 
insecticides, which may be harmful 
to the environment. Synthetic drug 
manufacturing produces significant 
amounts of hazardous waste. OCGs dump 
this waste away from their production 
sites in order to conceal their activities. 
Dump sites are often highly contaminated 
and require a lengthy and costly clean-up 
process.
Europol’s support in the 
fight against the drug trade
Europol is the EU’s law enforcement 
agency and assists the Member States in 
their fight against serious international 
crime and terrorism. Established as an EU 
agency in 20095, Europol, the European 
Union Agency for Law Enforcement 
Cooperation, is at the heart of the 
European security architecture and offers 
a unique range of services. Europol is 
a support centre for law enforcement 
5  Council Decision of 6 April 2009 establishing the 
European Police Office (Europol) (2009/371/JHA), 
accessible at https://www.europol.europa.eu/
publications-documents/council-decision-of-6-april-
2009-establishing-european-police-office-europol 
operations, a hub for information on criminal activities as 
well as a centre for law enforcement expertise. Analysis is at 
the core of Europol’s activities. To give its partners deeper 
insights into the crimes they are tackling, Europol produces 
regular assessments that offer comprehensive, forward-
looking analyses of crime and terrorism in the EU.
Europol supports the Member States in the fight against 
illegal drugs with a team of experienced specialists and 
analysts based in the European Serious and Organised Crime 
Centre. They provide operational, coordination and analysis 
support to investigating officers in the Member States.
A large share of the information flowing to Europol from 
EU law enforcement authorities concerns drug-related 
investigations and operations. In 2016, information related 
to drugs and migrant smuggling were the most frequently 
exchanged type of information via Europol. The number 
of contributions related to drug-criminality received by 
Europol has steadily increased over the last years. In 2016, 
Europol received more than 9000 contributions related to 
the trade in illegal drugs. Currently, Europol supports more 
than 100 high-priority cases at an international level often 
involving multiple Member States and partner countries 
targeting sophisticated criminal organisations involved in 
the production, trafficking and distribution of illegal drugs. 
Europol continuously supports Member States in executing 
complex operations targeting high-value targets that often 
result in the seizure of very significant amounts of various 
types of drugs.
The EU Policy Cycle for Serious and 
Organised Crime
The Policy Cycle provides a robust framework that brings 
together the law enforcement authorities of the Member 
States, Europol and a wide range of multi-disciplinary 
partners in the fight against serious and organised crime. 
The Policy Cycle translates strategic objectives at the 
European level into concrete operational actions against 
serious and organised crime.
Based on the analytical findings of the European Union 
Serious and Organised Threat Assessment (EU SOCTA) 
2017, the Justice and Home Affairs Council of the EU set 
the priorities for the fight against serious and organised 
crime for the second full policy cycle from 2018 to 2021 
in May 2017. The Council Conclusions clearly identify the 
production, trafficking and distribution of illegal drugs as a 
key priority in the fight against serious and organised crime:
To (1) disrupt the activities of Organised Crime Groups (OCGs) 
involved in the wholesale trafficking of cannabis, cocaine and 
heroin to the EU, to (2) tackle the criminal networks involved 
in the trafficking and distribution of multiple types of drugs 
on EU markets and to (3) reduce the production of synthetic 
drugs and New Psychoactive Substances (NPS) in the EU and 
to dismantle OCGs involved in their production, trafficking 
and distribution.
This priority will largely determine the operational work 
carried out in the framework of the Policy Cycle for the next 
four years.
High-level conference 
at Europol to discuss 
enhancing the fight against 
illegal drugs
In addition to operational support, 
Europol also works with Member States 
and Third Partners to establish a joint 
strategic approach in fighting drug-
related criminality. On 6 and 7 December 
2017, the Heads of Drugs Units of all 
Member States, representatives of 
relevant Third Partners and EU agencies 
such as Eurojust and the European 
Monitoring Centre for Drugs and Drugs 
Addiction will gather at Europol to 
identify and discuss the implementation 
of new ways to tackle one of the most 
threatening criminal phenomena in the 
EU – the trade in illegal drugs.
The conference complements the 
Evaluation of the implementation of the 
EU Drugs Strategy 2013-2020 and the EU 
Action Plan on Drugs 2013-2016 by the 
European Commission. According to this 
evaluation, available evidence shows that 
there has been at least some progress in 
all EU Action Plan actions aimed at drug 
supply reduction, however, a significant 
reduction of the supply of drugs was not 
recorded in recent years.
Building on the findings of the evaluation, 
the new Action Plan on Drugs 2017-2020 
provides a strengthened response to 
the newly-emerging health and security 
challenges in the area of illicit drug use 
and trafficking. While maintaining and 
updating the core policy areas and cross-
cutting themes of the overall EU Drugs 
Strategy, the new Action Plan identifies 
new priority areas for action, including 
the monitoring of new psychoactive 
substances as well as the use of new 
communication technologies in illicit drug 
production and trafficking and evidence 
gathering on the potential connection 
between drug trafficking and financing 
of terrorist groups, organised crime, 
migrant smuggling or trafficking in human 
beings.
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The Darknet trade in illegal 
drugs
The Darknet has emerged as a key 
platform to offer all types of illicit goods 
and services. Difficult to police yet easy 
to access, the Darknet provides an ideal 
environment for the distribution of all 
types of illegal commodities including 
drugs, firearms, child abuse material, 
counterfeit goods,  and fraudulent 
documents. The trade in illegal drugs 
is the mainstay of most major Darknet 
markets. The majority of activity on 
Darknet markets is drug related, with 
some studies estimating that 57% of Dark 
market listings offer drugs. It is estimated 
that the top 1% most successful 
vendors are responsible for 51.5% of all 
transactions on Darknet markets.6 While 
it is assessed that the majority of vendors 
6 Carnegie Mellon University 2015, Measuring the 
Longitudinal Evolution of the Online Anonymous 
Marketplace Ecosystem, available at https://www.
usenix.org/system/files/conference/usenixsecurity15/
sec15-paper-soska-updated.pdf  
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09are lone offenders, dealing in small amounts, it is reported that many of the 
‘top sellers’ are likely organised crime 
groups earning significant profits.
Darknet marketplaces are attractive 
platforms for clients and vendors alike. 
They provide an anonymous and secure 
environment to trade all types of illegal 
drugs and other illegal commodities. The 
use of cryptocurrencies allows vendors 
and clients to exchange payments with 
little trace and represent a significant 
hurdle in the attribution of transactions 
to specific users. The trust and reputation 
system used by Darknet marketplaces 
emulates those established by legal 
trading platforms on the surface web.  
The trade in illegal drugs on Darknet 
marketplaces has resulted in a significant 
increase in the use of post and parcel 
services to traffic drugs across the EU.
New psychoactive 
substances (NPS) on 
European drug markets
Previously unknown NPS continue to 
appear on EU markets in large numbers. 
Since 2005, 620 new substances 
were detected in the EU for the first 
time.7 NPS are initially not covered by 
international drug controls and include 
various substances such as synthetic 
cannabinoids, stimulants, opioids and 
benzodiazepines. In many cases these 
NPS emulate the effect of traditional 
drugs such as cannabis or cocaine and are 
marketed as alternatives for these drugs.
The consumption of NPS entails 
significant risks to the health of users 
including lethal overdose. In 2015, the 
synthetic opioid acetylfentanyl was linked 
to 32 deaths in Europe.8 Many other 
NPS have been linked to health risks and 
deaths in the EU over recent years. 
NPS continue to be produced in China 
and, to a lesser degree, India and 
trafficked to the EU in large quantities. 
NPS are sold on online marketplaces and 
distributed via postal and parcel services 
across Europe. NPS are shipped to the EU 
in bulk where these substances are often 
processed and packaged for distribution.
Fentanyl and its analogues 
– deadly synthetic opioids9
The fentanils are a family of highly potent 
opioid narcotic drugs. A small number are 
widely used as medicines in anaesthesia, 
for pain relief, and the immobilisation of 
large animals. Due to their psychoactive 
effects, such as causing euphoria, they 
are also used as replacements for heroin 
and other illicit opioids. Typically, use 
of very small amounts of fentanils can 
quickly poison an individual by causing 
central nervous system depression and 
respiratory depression. Left untreated, 
poisoning may cause death.
While some fentanils on the European 
7 EMCDDA 2017, European Drugs Report 2017
8 EMCDDA & Europol 2016, EU Drug Markets Report 
2016
9 Based on a contribution by the EMCDDA (November 
2017)
Fentanyl deaths: 
Warning as drug 
kills ‘at least 60’10
At least 60 people have 
died in the UK in the last 
eight months after taking 
the strong painkiller 
fentanyl. 
Tests on heroin 
seized by police since 
November found traces 
of the synthetic drug, 
with more than 70 
further deaths pending 
toxicology reports, the 
National Crime Agency 
(NCA) said. 
Some contained 
carfentanyl, which is 
10,000 times stronger 
than morphine and 
often used to tranquillize 
elephants. Health 
officials and police have 
warned heroin users to 
be “extra careful”. They 
were predominantly men 
and a range of ages, with 
none younger than 18.
Recent NCA 
investigations found 
that fentanyl and its 
analogues are being both 
supplied in and exported 
from the UK.
10 BBC News 2017, Fentanyl deaths: 
Warning as drug kills ‘at least 60’ 
[1 August 2017], accessible at 
http://www.bbc.com/news/uk-
england-40793887
10
drug markets are medicines diverted 
from legal supply, many are deliberately 
produced for the illicit drugs market. 
There has been large increase in the 
availability of fentanils on the European 
illicit drug market in the past few years 
mainly as a result of bulk production in 
China and their online sale. Reports of 
deaths have also substantially increased.
Since 2012, a total of 24 new fentanils 
have been identified on Europe’s drug 
market — including 14 since January 
2016. During this period there has also 
been a large increase in seizures by law 
enforcement at international borders and 
at street-level. Reports of fatal poisonings 
have also increased substantially. 
Where known, the vast majority of 
shipments of new fentanils coming 
into Europe originate from chemical 
and pharmaceutical companies based 
in China. However, production in illicit 
laboratories, including in Europe, have 
also been reported. Typically, synthesis of 
fentanils is relatively straightforward.
As new fentanils are not controlled 
under the United Nations international 
drug control conventions they can be 
manufactured and traded relatively freely 
and openly in many countries — which 
has been exploited by entrepreneurs 
and organised crime using chemical and 
pharmaceutical companies based in 
China. The fentanils are typically shipped 
to Europe by express mail services and 
courier services. They are then sold as 
‘legal’ replacements to illicit opioids 
on the surface web and anonymous 
marketplaces on the darknet. Unknown 
to users, they are also sold directly on 
the illicit drug market as heroin or mixed 
with heroin, as counterfeit medicines, 
and as other illicit drugs such as cocaine. 
This places users at serious risk of life-
threatening poisoning.
Fentanyl and fentanyl analogues available 
on European drug markets are either licit 
pharmaceutical products diverted from 
legal supply or illicit drugs produced in 
clandestine laboratories. The potency of 
illegally produced fentanils is typically 
higher than those diverted from legal 
supply and their effect on the users is 
therefore less predictable.
Two major law enforcement operations, led by the Federal 
Bureau of Investigation (FBI), the US Drug Enforcement 
Agency (DEA) and the Dutch National Police, with the 
support of Europol, have shut down the infrastructure of an 
underground criminal economy responsible for the trading 
of over 350 000 illicit commodities including drugs, firearms 
and cybercrime malware. The coordinated law enforcement 
action in Europe and the US ranks as one of the most 
sophisticated take-down operations ever seen in the fight 
against criminal activities online.
AlphaBay was the largest criminal marketplace on the 
Dark Web, utilising a hidden service on the Tor network to 
effectively mask user identities and server locations. Prior 
to its take-down, AlphaBay reached over 200 000 users and 
40 000 vendors. There were over 250 000 listings for illegal 
drugs and toxic chemicals on AlphaBay, and over 100 000 
listings for stolen and fraudulent identification documents 
and access devices, counterfeit goods, malware and other 
computer hacking tools, firearms, and fraudulent services. 
　A conservative estimation of USD 1 billion was transacted 
in the market since its creation in 2014. Transactions were 
paid in Bitcoin and other cryptocurrencies. Hansa was the 
third largest criminal marketplace on the Dark Web, trading 
similarly high volumes in illicit drugs and other commodities. 
The two markets were created to facilitate the expansion 
of a major underground criminal economy, which affected 
the lives of thousands of people around the world and 
was expressly designed to frustrate the ability of law 
enforcement to bring offenders to justice.
THE INVESTIGATIONS
Europol has been supporting the investigation of criminal 
marketplaces on the Dark Web for a number of years. 
Europol and partner agencies supported the Dutch National 
Police to take over the Hansa marketplace on 20 June 2017 
under Dutch judicial authorisation, facilitating the covert 
monitoring of criminal activities on the platform until it 
was shut down on 20 July 2017. The Dutch Police collected 
valuable information on high value targets and delivery 
addresses for a large number of orders. Some 10 000 
foreign addresses of Hansa market buyers were passed on 
to Europol.
In the meantime, an FBI and DEA-led operation, called 
Bayonet, was able to identify the creator and administrator 
of AlphaBay, a Canadian citizen living a luxurious life in 
Thailand. On 5 July 2017, the main suspect was arrested in 
Thailand and the site taken down. Millions of dollars’ worth 
of cryptocurrencies were frozen and seized. Servers were 
also seized in Canada and the Netherlands.
L AW ENFORCEMENT STRATEGY
In shutting down two of the three largest criminal 
marketplaces on the Dark Web, a major element of the 
infrastructure of the underground criminal economy 
has been taken offline. It has severely disrupted criminal 
enterprises around the world, has led to the arrest of key 
figures involved in online criminal activity, and yielded 
huge amounts of intelligence that will lead to further 
investigations. But what made this operation really special 
was the strategy developed by the FBI, DEA, the Dutch 
Police and Europol to magnify the disruptive impact of 
the joint action to take out AlphaBay and Hansa. This 
involved taking covert control of Hansa under Dutch 
judicial authority, which allowed Dutch police to monitor 
the activity of users without their knowledge, and then 
shutting down AlphaBay during the same period. It meant 
the Dutch police could identify and disrupt the regular 
criminal activity on Hansa but then also sweep up all those 
new users displaced from AlphaBay who were looking for 
a new trading platform. In fact they flocked to Hansa in 
their droves, with an eight-fold increase in the number of 
new members of Hansa recorded immediately following 
the shutdown of AlphaBay. As a law enforcement strategy, 
leveraging the combined operational and technical 
strengths of multiple agencies in the US and Europe, it has 
been an extraordinary success and a stark illustration of the 
collective power the global law enforcement community can 
bring to disrupt major criminal activity.
  
  
USERS
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Major international law enforcement operations 
shut down AlphaBay and Hansa
AlphaBay was taken 
down on 4 July 
2017  
Two weeks later, the 
number of users in 
HANSA increased 
eightfold
The Dutch Police 
shut down Hansa 
marketplace on 20 
July 2017
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Cannabis remains, by far, the most 
widely consumed illegal drug in the EU. 
Cannabis is distributed on EU markets as 
cannabis resin and herbal cannabis. In 
recent years, herbal cannabis has been 
increasingly popular with consumers, 
which has led to an increase in the 
production and availability of herbal 
cannabis within the EU and in countries 
close to EU markets. Market stability 
indicates the success of the business 
model of the OCGs involved in this crime 
area as well as the key role played by 
organised crime in the trade in this illegal 
drug. 
Cannabis is set to remain popular with 
consumers and, as a consequence, will 
continue to generate significant profits 
for the OCGs involved in its production, 
trafficking and distribution. The indoor 
cultivation of herbal cannabis has proven 
a successful business model for OCGs 
and various groups will likely continue to 
invest in cultivation sites across the EU.
PRODUC TION IN THE EU
The production of herbal cannabis within 
the EU for domestic consumption has 
increased significantly over recent years. 
The indoor and outdoor cultivation of 
herbal cannabis in the Member States 
or in countries close to EU consumer 
markets is now likely the main source of 
herbal cannabis distributed in the EU. 
Indoor cultivation of cannabis takes place 
in most, if not all, Member States on 
different scales. 
12 Growing equipment, seeds and other raw 
materials used for cannabis cultivation 
in the EU are available online. Growing 
technologies have advanced allowing 
OCGs to automate the maintenance 
of cultivation sites and reduce the risk 
of detection. The indoor cultivation of 
herbal cannabis in the EU is expected 
to further expand over the coming 
years with new growing techniques 
and increasingly sophisticated growing 
technologies being used by OCGs in order 
to increase harvest yields and profits. 
TRAFFICKING
Albania remains the main source of 
herbal cannabis trafficked to the EU. The 
main source of cannabis resin consumed 
in the EU is Morocco from where it is 
trafficked to the EU primarily by sea and 
road transport. Cannabis resin originating 
from Morocco is increasingly smuggled 
to the EU across the Mediterranean Sea 
departing from Libya. 
Using front companies and middlemen, 
some OCGs operate their own cargo 
vessels or even small fleets of cargo 
vessels transporting multi-tonne 
shipments of cannabis. Cannabis resin 
is trafficked to the EU in containers 
concealed among legal goods. 
Cocaine
The trafficking and distribution of cocaine 
is the most common criminal activity 
related to drugs among OCGs active 
in the EU and generates multi-billion 
profits for the criminal actors involved. 
The annual retail market for cocaine in 
Europe is conservatively estimated at 
EUR 5.7 billion. OCGs involved in cocaine 
trafficking collaborate extensively in the 
trafficking and distribution of cocaine to 
an extent that it is difficult to delineate 
between the different OCGs involved in 
the trafficking activity in South America, 
Africa and the EU. 
PRODUC TION
Cocaine is primarily produced in 
Colombia, Peru and Bolivia and trafficked 
to the EU via other South American 
countries, the Caribbean Sea region 
and West Africa. Colombia remains the 
biggest producer of cocaine in the world. 
TRAFFICKING
Cocaine is typically trafficked as part 
of large shipments in containers and 
marine vessels or in smaller quantities 
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Significant increase 
in cocaine trafficking 
activities and seizures in 
the EU
Over the last three years, the production 
of cocaine in Colombia has intensified 
significantly following a peace accord 
between the government of Colombia 
and Revolutionary Armed Forces 
of Colombia - People’s Army (FARC) 
insurgents. The production output of 
cocaine increased by 60% from 2014 
to 2015.11 Between 2015 and 2016, 
Colombian coca cultivation areas 
expanded by 52% representing a further 
increase in production output of 34% 
11 United States Department of State 2017, International 
Narcotics Control Strategy Report. Vol I, Drug and 
Chemical Control.
compared to the previous year.12  
This unprecedented increase in cocaine 
production has resulted in intensified 
trafficking activity to the EU. While the 
established routes and modi operandi 
such as the trafficking of cocaine in 
containers and the use of couriers have 
largely remained the same, the number 
and quantities of cocaine seizures in the 
EU have notably increased.
12 UNODC 2017, UNODC Colombia Cultivation Survey, 
accessible at http://www.unodc.org/documents/
colombia/2017/julio/CENSO_2017_WEB_baja.pdf
13
by couriers. In some cases, OCGs use 
smaller leisure boats as well light aircraft 
to smuggle cocaine to and within the EU. 
Most cocaine trafficked in containers 
arrives in the EU at major sea ports, 
where OCGs often rely on corrupt port 
workers and other staff to extract the 
cocaine shipments from the containers. 
Cocaine trafficked by air arrives at major 
EU airports often following multiple 
changes as part of the couriers’ journey 
in order to obscure their original point 
of departure.  Smaller shipments of 
cocaine are frequently trafficked to 
the EU in couriers’ luggage or by body-
packers. Cruise ships departing from the 
Caribbean Sea region are increasingly 
being used to traffic cocaine to the EU.
Cocaine also continues to be smuggled 
incorporated into other items or as 
liquid odourless substances and is later 
extracted and converted into cocaine 
hydrochloride in dedicated secondary 
extraction and conversion laboratories. 
The EU is increasingly used as a 
transhipment point for cocaine trafficked 
from South America to destinations in 
Asia and the Middle East.
14
Heroin
OCGs active in the trafficking and 
distribution of heroin rely on an 
established and successful business 
model generating significant profits. 
Despite a reported moderate decline 
in heroin consumption levels in the EU, 
heroin continues to be trafficked to the 
EU in large quantities. 
PRODUC TION
Afghanistan remains the leading producer 
of heroin trafficked to the EU. The 
production output of opium and heroin in 
Afghanistan is very high and is projected 
to remain so for the foreseeable future. 
The estimated Afghan production output 
of opium in 2016 is approximately 
4800 tonnes, which could yield more 
between 290 and 510 tonnes of heroin 
in production.13 OCGs are thought to use 
established trafficking infrastructure to 
traffic acetic anhydride, the precursor 
used for heroin production, in large 
quantities. 
TRAFFICKING
A large share of the heroin consumed 
in the Member States is trafficked via 
the Balkan route to the EU - overland, 
by sea or by air. Repeated large seizures 
indicate the growing importance of the 
Caucasus route.  The Southern Caucasus 
region is an alternative transit hub for the 
trafficking of large quantities of heroin 
from Iran to the EU.  
OCGs involved in heroin trafficking 
increasingly traffic heroin in large 
individual shipments in excess of 100 
kilograms per shipment. Large shipments 
are also transported via the Southern 
route, with East Africa and South Africa 
as transhipment points, to key ports in 
Western Europe.
Couriers continue to be used to 
traffic heroin to the EU. Heroin is also 
available on online marketplaces and is 
occasionally distributed across the EU 
in small quantities via post and parcel 
services.
13 United Nations Office for Drugs and Crime (UNODC) 
2016, Afghanistan Opium Survey 2016, p. 38, accessible 
at https://www.unodc.org/documents/press/releases/
AfghanistanOpiumSurvey2016.pdf 
Synthetic drugs and NPS
The market for synthetic drugs continues 
to be most dynamic of the drugs markets 
in the EU. OCGs based in the EU remain 
among the most prolific producers of 
various types of synthetic drugs in the 
world.  
PRODUC TION
The production of different types 
of synthetic drugs takes place in 
various Member States. The intended 
destination markets for synthetic drugs 
produced in the EU vary according to 
the substance and production location. 
A share of the large-scale production of 
3,4-methylenedioxy-methamphetamine 
(MDMA), amphetamine and, to a lesser 
extent, methamphetamine in the EU 
is intended for trafficking to markets 
outside the EU, while the production of 
synthetic drugs in other parts of the EU 
predominantly supplies domestic and 
neighbouring EU markets.
PRECURSORS AND               
PRE-PRECURSORS
OCGs producing synthetic drugs in the 
EU continue to be highly flexible and 
will remain so in the future. They are 
quick to adopt alternative precursor and 
pre-precursor substances in reaction to 
any shortages in established precursor 
substances.  Some OCGs have specialised 
in the procurement and production of 
pre-precursor and precursor substances 
supplying OCGs producing and 
distributing synthetic drugs in the EU.
TRAFFICKING
Synthetic drugs produced in the EU 
are trafficked within the EU and to 
destination markets outside the EU 
mainly by couriers and parcels. Larger 
shipments trafficked within the EU are 
typically concealed in private vehicles and 
on lorries. In some cases, large shipments 
of synthetic drugs are trafficked to 
destinations outside the EU in maritime 
shipping containers. 
Terrorism
Terrorism and the groups carrying 
out terrorist offences have evolved 
significantly over the last decade. The EU 
has been the target of repeated terror 
attacks and plots in recent years. The 
trafficking and sale of illegal drugs in 
the EU is believed to primarily finance 
terrorist activities outside the EU. 
The pursuit of criminal activities in 
support of terrorist activities is not a 
new phenomenon.  Routes used to traffic 
cannabis and heroin traverse the same 
regions, such as the Western Balkans, 
that are also linked to terrorism-related 
activities including terrorism financing. 
The actors involved in terrorism with 
links to serious and organised crime use 
criminal infrastructures to facilitate their 
terrorism-related activities.
EU-based criminals specialising in 
the production of synthetic drugs 
are believed to be involved in the 
production of amphetamine used to 
manufacture “captagon” in the Middle 
East. “Captagon” is a popular drug in the 
Middle East and known to be used as a 
psychostimulant in combat situations. 
The trade in this substance is likely a 
source of finance for the activities of 
terrorist actors.  
Money laundering
Money laundering allows OCGs to 
introduce the proceeds of crime into the 
legitimate economy. Almost all criminal 
groups need to launder profits generated 
from criminal activities. The trade in 
illegal drugs generates substantial 
profits for the OCGs involved.  In some 
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cases, these OCGs launder these funds 
by themselves investing in businesses, 
real estate and other ventures across 
and outside the EU. However, the most 
successful drug trafficking networks 
also make use of money laundering 
syndicates, which have specialised in 
laundering the proceeds of other OCGs in 
exchange for a fee.
The scale of money laundering activities 
in the EU is significant reflecting the 
immense profits generated by the OCGs 
involved in the drugs trade and other 
serious and organised crime. However, 
the global anti-money laundering 
framework implemented by law 
enforcement and other authorities in the 
EU has shown to have a poor success rate 
in identifying and seizing illegal funds 
generated by criminal organisations. 
Between 0.7-1.28% of annual EU GDP is 
detected as being involved in suspect 
financial activity. In 2014, EU Financial 
Intelligence Units (FIUs) received almost 
1 million reports. Although the overall 
number of suspicious transaction 
reports (STRs) continues to increase, 
only around 10% of these reports are 
further investigated – a figure that is 
largely unchanged since 2006. Even 
where further investigated, the likelihood 
of successful asset recovery is low, 
and barely 1% of criminal proceeds are 
confiscated by relevant authorities at EU 
level. 14
Money laundering is also increasingly a 
technical challenge for law enforcement 
authorities. Criminal networks 
continuously seek to exploit the latest 
technological developments such as 
cryptocurrencies and anonymous 
payment methods. Rapid transaction 
processing and the proliferation of 
effective anonymisation tools are 
significant obstacles in the identification 
of the beneficial owners of criminal 
proceeds. A growing number of online 
platforms and applications offer new 
ways of transferring money and are not 
always regulated to the same degree as 
traditional financial service providers.
14 Europol 2017, From Suspicion to Action - Converting 
financial intelligence into greater operational impact, 
accessible at https://www.europol.europa.eu/sites/
default/files/documents/ql-01-17-932-en-c_pf_final.
pdf
www.europol.europa.eu
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